Manufacturers are racing to produce enough Covid vaccines for the world. However, as many as 130 countries have yet to start vaccinating because of a lack of supply. But what if medications that already exist could be repurposed to tackle Covid-19? What if a cheap anti-parasitic drug that is already approved by the World Health Organization (WHO) and the FDA could help save lives?
On January 26, the Slovakia Republic’s Minister of Health, formerly registered Ivermectin as an approved prophylaxis and treatment for SARS-CoV-2, the virus behind COVID-19. Making it the first European Union nation to do so.
With a growing number of studies indicating the potential efficacy of ivermectin, the inexpensive drug has become difficult to ignore. It has reached a point where the Bill and Melinda Gates Foundation have included ivermectin in their clinical trial called the Together COVID-19 Trial.
Following the findings presented at the US Senate Hearing on Dec 7, 2020, the National Institutes of Health (NIH), on Jan 14, changed their stance on Ivermectin from “against” for the treatment of Covid-19 to “neither for or against,” thereby making it an option for doctors treating Covid-19. The presenters were Dr Pierre Kory, President of FLCCC (Front Line Covid-19 Critical Care) Alliance and Dr Andrew Hill, Researcher & Consultant to World Health Organisation (WHO).
The upgrade by NIH might seem small, but it has a significant impact on doctors who are now free to use Ivermectin without feeling the undue pressure or burden to do so. There have been two cases (case 1, case 2) where a judge had to get involved and order hospitals to continue the use of ivermectin after both patients showed improvement. Fortunately, such instances will no longer occur under the new change.
Not a ‘Miracle Drug’ but Part of the Regimen
A medical director for seven Western New York skilled nursing facilities says he has been using Ivermectin to help elderly patients fight Covid-19. But he believes it has helped 80 out of 90 of his patients recover at an Elderwood nursing home for Covid-19 patients in Amherst.
“I am not trying to become the poster boy for Ivermectin. I’m not calling it a miracle drug. But it is part of the regimen of drugs we now use to treat Covid patients,” Shields told The Buffalo News. Shields and two other Buffalo area physicians have used the inexpensive drug to treat more than 100 Covid patients.
Dr. Thomas Madejski, a former president of the New York State Medical Society, said he has also used Ivermectin as an effective treatment for Covid-19 patients in Erie, Niagara and Orleans counties.
And Dr. Zerline Snyderman, a medical director for the McGuire Group, told The News that they have had success using the drug to treat Covid-19 patients at its Harris Hill Nursing Facility in Amherst, which specializes in coronavirus care.
The McGuire facility at Harris Hill and the Elderwood facility in Amherst are two of the busiest Covid-19 treatment facilities in Western New York.
Ivermectin, an anti-parasitic & anti-viral drug, was originally developed by Japan in 1975. More than 3.7 billion doses have been distributed globally and used by many millions of people during the last 30 years or so, with no reported adverse side effects or deaths from people taking it.